… evidence supporting the therapeutic value of NLRP3 inflammasome-targeted strategies in
… of the NLRP3 inflammasome in AMI and its consequences on adverse cardiac remodelling, …

… of the NLRP3 inflammasomes and their activation, which results in processing and release of
IL-1β. The NLRP3 inflammasomes contain NLRP3 … The NLRP3 inflammasome activation is …

… The NLRP3 inflammasome is primed and triggered by locally released damage-associated …
role for NLRP3 in AMI and the available strategies to inhibit the effects of the inflammasome. …

… , cardiac fibroblasts, and … NLRP3 inflammasome may be a potential target for the prevention
and therapy of MI. This review summarizes recent knowledge on NLRP3 inflammasome …

… cardiac dysfunction and remodeling in rodent models of MI. Therefore, the regulation of NLRP3
inflammasome … role of NLRP3 inflammasome in the process of cardiac inflammation and …

… damage and reduces heart fibrosis, improving cardiac remodeling, as … NLRP3 inflammasome
in heart tissue and suppresses the recruitment of inflammatory mediators in cardiac …

… asymptomatic individuals with high risk of acute myocardial infarction (AMI). However, AMI
… We propose to evaluate the NLRP3–inflammasome complex as a potential conventional …

… Successful reperfusion is the most effective strategy to reduce ischemic injury in acute
myocardial infarction (AMI). Ischemic injury, however, also triggers a secondary ischemia–…

… Here in this study, we also demonstrated an increase of the NLRP3 inflammasome-related
proteins including NLRP3 and ASC in the heart tissue on the occurrence of MI as well as …

… the role of the NLRP3 inflammasome in atherosclerosis, CAD, and myocardial I/R injury.
Furthermore, the current therapeutic approaches targeting the NLRP3 inflammasome and its …